Financials · mywealthgrid

Loading page…

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	14,256	17,494	15,560	16,369	15,375	15,163	16,405	16,642	20,011	22,708	27,958
COGS	4,778	5,339	5,274	5,846	5,431	5,362	6,481	6,780	6,643	6,842	7,326
Gross profit	9,477	12,155	10,285	10,524	9,944	9,801	9,924	9,862	13,367	15,866	20,632
	5,792	7,662	7,379	7,990	7,585	7,233	9,637	8,064	9,557	10,582	11,816
	3,685	4,493	2,907	2,533	2,359	2,568	288	1,798	3,811	5,283	8,816
OPM %	25.9%	25.7%	18.7%	15.5%	15.3%	16.9%	1.8%	10.8%	19%	23.3%	31.5%
Depreciation	487	912	1,086	1,085	970	887	1,659	881	1,197	1,169	1,376
Interest	59	153	204	308	363	141	143	274	312	295	434
	185	107	-1,070	377	-138	136	142	73	120	196	-133
Profit before tax	3,329	3,543	547	1,517	887	1,676	-1,372	716	2,422	4,015	6,873
Tax	1,059	979	288	902	1,157	449	137	269	487	709	1,517
Tax %	31.8%	27.6%	52.8%	59.4%	130.4%	26.8%	10%	37.5%	20.1%	17.7%	22.1%
	2,270	2,565	258	615	-270	1,228	-1,509	448	1,936	3,306	5,355
PAT margin %	15.9%	14.7%	1.7%	3.8%	-1.8%	8.1%	-9.2%	2.7%	9.7%	14.6%	19.2%
EPS (₹)	50.3	56.7	30.8	34.3	-6	27.1	-33.7	9.5	42.1	72	116.8
EPS adjusted (₹)	50.2	56.6	5.6	13.4	-13.5	26.8	-33.6	9.5	42	71.9	116.6
	14.9%	13.2%	16.2%	14.6%	—	24%	—	42.3%	19%	16.7%	15.4%
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	90	90	90	91	91	91	91	91	91	91	91
Reserves	10,894	13,407	13,487	13,652	12,446	13,712	12,062	12,374	14,199	17,112	22,357
Minority interest	—	—	—	—	—	55	69	78	83	91	65
	7,119	—	—	—	—	4,783	3,844	4,244	2,670	5,077	5,910
	4,334	13,110	12,728	14,207	12,447	4,969	5,755	6,169	6,954	6,834	9,941
Total equity & liabilities	22,438	26,607	26,305	27,949	24,984	23,610	21,821	22,956	23,997	29,205	38,365
	3,262	8,723	7,914	8,706	7,938	7,881	7,382	8,355	8,878	9,719	10,994
CWIP	981	715	956	1,019	758	852	847	895	596	355	695
Investments	8	2,120	240	2,270	2,344	2,455	900	517	1,075	1,146	3,670
	18,187	15,050	17,195	15,954	13,944	12,423	12,692	13,189	13,449	17,984	23,006
Total assets	22,438	26,607	26,305	27,949	24,984	23,610	21,821	22,956	23,997	29,205	38,365

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.

Source XBRL ↗

Latest reported period · 31 Mar 2026 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities	Capital employed	ROCE %
Pharmaceuticals	27,812.36	7,050.27	38,128.6	15,746.22	22,382.38	31.5
Others	147.39	-177.72

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-369	4,114	209	3,111	1,469	1,239	1,082	1,934	3,490	430	7,546
	-6,943	-2,527	725	-2,865	1,107	-657	577	-1,324	-1,554	-1,602	-4,076
	5,813	433	-987	-295	-891	-1,885	-1,572	-337	-2,184	1,732	-846
Net cash flow	-1,500	2,019	-52	-50	1,685	-1,303	87	273	-248	560	2,624
Free cash flow	—	—	—	—	—	562	177	435	2,562	-1,252	5,491
CFO / Operating profit %	-10%	91.6%	7.2%	122.8%	62.4%	48.3%	376.9%	107.6%	91.6%	8.1%	85.6%